Cargando…
Age-Dependent Reduction in Neutralization against Alpha and Beta Variants of BNT162b2 SARS-CoV-2 Vaccine-Induced Immunity
Vaccines against severe acute respiratory syndrome coronavirus-2 have been introduced. To investigate the relationship between vaccine-induced humoral immunity and patient age, we measured antibody levels and neutralization in vaccinated sera. Sera from 13 to 17 days after the second dose of the BNT...
Autores principales: | Kawasuji, Hitoshi, Morinaga, Yoshitomo, Tani, Hideki, Saga, Yumiko, Kaneda, Makito, Murai, Yushi, Ueno, Akitoshi, Miyajima, Yuki, Fukui, Yasutaka, Nagaoka, Kentaro, Ono, Chikako, Matsuura, Yoshiharu, Niimi, Hideki, Yamamoto, Yoshihiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8635122/ https://www.ncbi.nlm.nih.gov/pubmed/34851162 http://dx.doi.org/10.1128/Spectrum.00561-21 |
Ejemplares similares
-
Effectiveness of the third dose of BNT162b2 vaccine on neutralizing Omicron variant in the Japanese population()
por: Kawasuji, Hitoshi, et al.
Publicado: (2022) -
Neutralizing Antibody Response of the Wild-Type/Omicron BA.1 Bivalent Vaccine as the Second Booster Dose against Omicron BA.2 and BA.5
por: Kawasuji, Hitoshi, et al.
Publicado: (2023) -
Circulating Type I Interferon Levels in the Early Phase of COVID-19 Are Associated With the Development of Respiratory Failure
por: Nagaoka, Kentaro, et al.
Publicado: (2022) -
Effect of Casirivimab/Imdevimab Treatment on Serum Type I Interferon Levels in SARS-CoV-2 Infection
por: Nagaoka, Kentaro, et al.
Publicado: (2022) -
Correlation of the Commercial Anti-SARS-CoV-2 Receptor Binding Domain Antibody Test with the Chemiluminescent Reduction Neutralizing Test and Possible Detection of Antibodies to Emerging Variants
por: Morinaga, Yoshitomo, et al.
Publicado: (2021)